[HTML][HTML] Role of FGFR3 in bladder cancer: Treatment landscape and future challenges

CM Ascione, F Napolitano, D Esposito… - Cancer Treatment …, 2023 - Elsevier
Bladder cancer is a heterogeneous malignancy and is responsible for approximately 3.2%
of new diagnoses of cancer per year (Sung et al., 2021). Fibroblast Growth Factor Receptors …

The fibroblast growth factor signaling pathway

DM Ornitz, N Itoh - Wiley Interdisciplinary Reviews …, 2015 - Wiley Online Library
The signaling component of the mammalian Fibroblast Growth Factor (FGF) family is
comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF …

Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer

S Sudhesh Dev, SA Zainal Abidin… - Frontiers in …, 2021 - frontiersin.org
Receptor tyrosine kinases (RTKs) are transmembrane cell-surface proteins that act as signal
transducers. They regulate essential cellular processes like proliferation, apoptosis …

Agnostic approvals in oncology: getting the right drug to the right patient with the right genomics

V Tateo, PV Marchese, V Mollica, F Massari… - Pharmaceuticals, 2023 - mdpi.com
(1) Background: The oncology field has drastically changed with the advent of precision
medicine, led by the discovery of druggable genes or immune targets assessed through next …

The emerging complexity of gene fusions in cancer

F Mertens, B Johansson, T Fioretos… - Nature Reviews Cancer, 2015 - nature.com
Structural chromosome rearrangements may result in the exchange of coding or regulatory
DNA sequences between genes. Many such gene fusions are strong driver mutations in …

Discovery and pharmacological characterization of JNJ-42756493 (Erdafitinib), a functionally selective small-molecule FGFR family inhibitor

TPS Perera, E Jovcheva, L Mevellec… - Molecular cancer …, 2017 - aacrjournals.org
Fibroblast growth factor (FGF) signaling plays critical roles in key biological processes
ranging from embryogenesis to wound healing and has strong links to several hallmarks of …

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

FB Furnari, TF Cloughesy, WK Cavenee… - Nature Reviews …, 2015 - nature.com
As tumours evolve, the daughter cells of the initiating cell often become molecularly
heterogeneous and develop different functional properties and therapeutic vulnerabilities. In …

Phase I dose-escalation study of JNJ-42756493, an oral pan–fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

J Tabernero, R Bahleda, R Dienstmann… - Journal of clinical …, 2015 - ascopubs.org
Purpose JNJ-42756493 is an orally administered pan-fibroblast growth factor receptor
(FGFR) tyrosine kinase inhibitor. This first-in-human study evaluates the safety …

FGFR a promising druggable target in cancer: Molecular biology and new drugs

R Porta, R Borea, A Coelho, S Khan, A Araújo… - Critical reviews in …, 2017 - Elsevier
Abstract Introduction The Fibroblast Growth Factor Receptor (FGFR) family consists of
Tyrosine Kinase Receptors (TKR) involved in several biological functions. Recently …

Role of basic fibroblast growth factor in cancer: biological activity, targeted therapies, and prognostic value

A Ardizzone, V Bova, G Casili, A Repici, M Lanza… - Cells, 2023 - mdpi.com
Cancer is the leading cause of death worldwide; thus, it is necessary to find successful
strategies. Several growth factors, such as vascular endothelial growth factor (VEGF), basic …